For instance, by inhibiting the expression of miR-103 and miR-32-5p, GAS5 induces the PTEN/PI3K/AKT pathway, thereby suppressing the tumor progression of endometrial cancer [70] and pancreatic cancer cells [71]. This evidence concerns the gene GAS5 and endometrial cancer.